ask="9.9500"
ask_size="1000"
average_daily_volume="43919"
bid="6.5300"
bid_size="400"
book_value="0.0000"
change="+0.7295"
change_from_200_day_moving_average="-0.1097"
change_from_50_day_moving_average="-0.1229"
change_from_52_week_high="-33.8505"
change_From_52_week_low="1.3595"
change_in_percent="+10.8557%"
close="7.4495"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-8.0380"
ebitda="0.00"
eps_estimate_current_year="-1.0700"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-1.4100"
ex_dividend_date="N/A"
float_shares="N/A"
high="7.5379"
high_52_weeks="41.3000"
last_trade_date="1/6/2017"
last_trade_price="7.4495"
last_trade_size="100"
last_trade_time="3:59pm"
low="6.5000"
low_52_weeks="6.0900"
market_capitalization="73.94B"
moving_average_200_day="7.5592"
moving_average_50_day="7.5724"
name="KalVista Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.6400"
open="6.9473"
pe_ratio="1.0040"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-1.4513%"
percent_change_from_50_day_moving_average="-1.6225%"
percent_change_from_52_week_high="-81.9625%"
percent_change_from_52_week_low="+22.3235%"
previous_close="6.7200"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="9925000000"
short_ratio="0.0000"
stock_exchange="NGM"
symbol="KALV"
volume="93986"
weeks_range_52="6.0900 - 41.3000"
